Research and Policy CSR News

Carnival Cruise Line Named St. Jude Children’s Research Hospital’s ‘Corporate Partner of the Year’

World’s most popular cruise line recognized for outstanding support through innovative fundraising activities and on-site events
Press Release

MIAMI, June 21, 2018 /3BL Media/ – Carnival Cruise Line – which has raised more than $16 million for St. Jude Children’s Research Hospital over the past eight years and serves as its Official Celebration Partner – has been named the organization’s “Corporate Partner of the Year” for its outstanding support through innovative fundraising activities and engaging on-site events for patients.

Shire Commitments to Support Patients as Part of Responsibility Strategy

Article

At Shire, supporting patients is at the heart of being a champion for patients. Beyond discovering and developing medicines, we are committed to dramatically shortening the time to diagnosis for rare diseases, and we aim to support patients along the entire patient journey, from conducting clinical trials to enabling patients to better manage their care through the use of innovative digital technologies, and beyond.

Merck for Mothers Publishes “Evidence for Impact” 2018 Research Compendium

Multimedia with summary

At Merck for Mothers, we believe that actionable research is essential for taking on maternal mortality. On behalf of our team and many partners, we are pleased to share Evidence for Impact, our first Research Compendium. The publications included in this compendium advance our collective understanding of the problem of maternal mortality, inform the design and implementation of programs aiming to improve women’s health, and strengthen the global health community of practice to save women’s lives.

Merck for Mothers Blog | Assessing and Addressing Maternal Sepsis

Read the latest blog post by Merck for Mothers guest authors Mercedes Bonet, a perinatal health epidemiologist at the World Health Organization and Vanessa Brizuela, a consultant at the World Health Organization
Blog

Every pregnant or recently pregnant woman is at risk of an infection that could trigger maternal sepsis. Sepsis is a life-threatening condition that occurs when the body’s response to infection causes injury to its own tissues and organs.

Despite it being one of the main causes of maternal death and leading to about 35,000 deaths every year, the true burden of maternal sepsis is presently unknown, due to a lack of data.

Bristol-Myers Squibb Foundation’s $25M Commitment to Cancer Moonshot Recognized at AACR Annual Meeting

Blog

The Bristol-Myers Squibb Foundation’s commitment to address health disparities in cancer outcomes and care was represented at the Biden Cancer Initiative event at AACR. In 2016, the Foundation joined the Cancer Moonshot initiative and donated $25M to grantee projects to expand community-based cancer care resources and patient engagement and support programs for racial and ethnic minorities, rural, low income and vulnerable populations in the U.S. Grantee projects are being implemented in over 25 states across the country.

 

All Good, All Year Pedals on with Cycle for Survival Fundraiser

by Michael Valentino
Blog

Another year, another Team Viacom success story.

In a continuing tradition central to Viacommunity’s All Good, All Year initiative, 24 Team Viacom employees in  New York and Los Angeles joined the battle to beat rare cancers by participating in Cycle for Survival’s 12th year of rides, helping to raise some of the more than $40 million in critical funds that the organization has raised for rare cancer research this season alone.

UNCF Announces Partnership with Bristol-Myers Squibb to Launch the UNCF Bristol-Myers Squibb E. E. Just Postgraduate Fellowship in the Life Sciences

New fellowship will transform postgraduate training and career opportunities for African American life scientists in academia and the biopharmaceutical industry R&D.
Press Release

WASHINGTON, D.C., February 28, 2018 /3BL Media/ -- UNCF today announced a partnership with Bristol-Myers Squibb (NYSE:BMY) to launch an innovative fellowship program in the life sciences that will transform the postgraduate training experience for African American scientists pursuing research careers in academic or biopharmaceutical industry research and development (R&D). Named in honor of Dr.

Ferring Pharmaceuticals and Merck Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Hemorrhage

Summary: 
  • Excessive Bleeding after Childbirth (Postpartum Hemorrhage or PPH) is the Leading Direct Cause of Maternal Mortality Worldwide
     
  • The CHAMPION Trial is Assessing the Effectiveness and Safety of Heat-Stable Carbetocin versus Oxytocin, the Current Standard of Care, for Preventing PPH After Vaginal Birth
Press Release
  • Excessive Bleeding after Childbirth (Postpartum Hemorrhage or PPH) is the Leading Direct Cause of Maternal Mortality Worldwide
     
  • The CHAMPION Trial is Assessing the Effectiveness and Safety of Heat-Stable Carbetocin versus Oxytocin, the Current Standard of Care, for Preventing PPH After Vaginal Birth

Well Living Lab Announces 3-year Research Plan to Study Effects of Indoor Surroundings on Health and Well-being

Press Release

ROCHESTER, Minn., February 21, 2018 /3BL Media/  – The Well Living Lab today announced an extensive three-year scientific research plan to identify how indoor environments effect five significant facets of people’s lives: health, performance, stress and resiliency, sleep and comfort. Studies will examine these factors for homes, workplaces and independent living communities.

Walking Forward Receives $1.6 Million Grant for Lung Cancer Screening Research

Press Release

SIOUX FALLS, S.D., February 20, 2018 /3BL Media/ – Avera Health is pleased to announce that the Walking Forward Program, based in Rapid City, has been awarded a grant for over $1.6 million from the Bristol-Myers Squibb Foundation to increase lung cancer screening rates for high-risk smokers living in western South Dakota.

The award, which will be distributed over the course of three years (2018-2020), will fund Walking Forward’s research dedicated to increasing awareness of lung cancer prevention and access to advanced lung cancer screening technology.

Pages

Subscribe to Research and Policy